BMI, body mass index; AF, atrial fibrillation; NYHA, New York Heart
Association; CHD, coronary heart disease; NT-ProBNP, N-terminal pro-B
type natriuretic peptide; eGFR, estimated glomerular filtration rate;
SUA, serum uric acid; ACEI, angiotensin converting enzyme inhibitor;
ARB, angiotensin II receptor antagonist; ARNI, angiotensin receptor
neprilysin inhibitor; MRA, mineralocorticoid receptor antagonist; AADs,
anti-arrhythmic drugs; TTE, transthoracic echocardiography; LAD, left
atrial diameter; LVEDD, left ventricular end-diastolic diameter; LVEF,
left ventricular ejection fraction.
Table 2 Univariate and multivariate analyses for risk factors of the
primary endpoint